Macular Degeneration: Treatments Have Similar Efficacy

Despite accumulating evidence, some remain unconvinced anti-VEGF agents are interchangeable. Should other factors, such as price, drive the clinical decision? It depends on who you ask.
Medscape Medical News

Full Story →